{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:54:39Z","timestamp":1774378479860,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jns.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T17:11:30Z","timestamp":1538759490000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Brain MRI findings in children and adolescents with Fabry disease"],"prefix":"10.1016","volume":"395","author":[{"given":"C.","family":"Marchesoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rollan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kisinovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rattagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Le\u00f3n Cejas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sevlever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Reisin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.10.009_bb0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.10.009_bb0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2018.10.009_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2018.10.009_bb0020","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.10.009_bb0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/08035320510028076","article-title":"Natural history of the cerebrovascular complications of Fabry disease","volume":"94","author":"Mehta","year":"2005","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.jns.2018.10.009_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.045","article-title":"Prevalence of Fabry disease in young patients with stroke in argentina","volume":"27","author":"Reisin","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0035","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2018.10.009_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","article-title":"Frequency of unrecognized Fabry disease among young European-American and African-American Men with first ischemic stroke","volume":"41","author":"Wozniak","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.10.009_bb0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of Fabry disease in stroke patients\u2014a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Cerebral microbleeds: a guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.03.020","article-title":"Brain MRI findings in patients with Fabry disease","volume":"305","author":"Reisin","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.10.009_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2005.03.004","article-title":"Radiological evidence of early cerebral microvascular disease in young children with Fabry disease","volume":"147","author":"Cabrera-Salazar","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jns.2018.10.009_bb0065","first-page":"37","article-title":"Evaluation of patients with Fabry disease in Argentina","volume":"70","author":"Asociaci\u00f3n Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales","year":"2010","journal-title":"Med. B Aires"},{"key":"10.1016\/j.jns.2018.10.009_bb0070","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"European task force on age-related white matter changes. A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.10.009_bb0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","article-title":"White matter lesion severity in male and female patients with Fabry disease","volume":"65","author":"Fellgiebel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.10.009_bb0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00415-008-0786-x","article-title":"The pulvinar sign: frequency and clinical correlations in Fabry disease","volume":"255","author":"Burlina","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0085","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2018.10.009_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00868342","article-title":"Stroke in Fabry's disease","volume":"241","author":"Grewal","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1017\/S0317167100002936","article-title":"Fabry's disease presenting as stroke in a young female","volume":"31","author":"Giacomini","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jns.2018.10.009_bb0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2005-2895","article-title":"Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease","volume":"118","author":"Ries","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jns.2018.10.009_bb0115","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1212\/WNL.0000000000002673","article-title":"Determinants of white matter hyperintensity burden in patients with Fabry disease","volume":"86","author":"Rost","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.10.009_bb0120","first-page":"231","article-title":"Fabry disease in Neurocutaneous syndromes. 3rd series","volume":"Vol. 132","author":"Schiffmann","year":"2015"},{"key":"10.1016\/j.jns.2018.10.009_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation","volume":"23","author":"Kaye","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0130","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/STROKEAHA.114.008548","article-title":"Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event","volume":"46","author":"Fazekas","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.10.009_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the Stroke in Young Fabry patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.10.009_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharm. Ther."},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.10.009_bb0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","article-title":"The cerebral vasculopathy of Fabry disease","volume":"257","author":"Moore","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.10.009_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2018.10.009_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"Degraba","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0160","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2018.10.009_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jns.2018.10.009_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_371","article-title":"Innate and adaptive immune response in Fabry disease","volume":"22","author":"Mauhin","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.jns.2018.10.009_bb0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cjca.2015.10.033","article-title":"Evaluation of proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy","volume":"32","author":"Chen","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jns.2018.10.009_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ki.2013.520","article-title":"Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease","volume":"86","author":"Shu","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.jns.2018.10.009_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.carpath.2009.10.003","article-title":"The heart in Fabry's disease","volume":"20","author":"Sheppard","year":"2011","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.jns.2018.10.009_bb0195","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bmj.1.5084.1418","article-title":"Angiokeratoma corporis diffusum","volume":"1","author":"Bass","year":"1958","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jns.2018.10.009_bb0200","first-page":"177","article-title":"Angiokeratoma corporis diffusum. A clinical study of eight affected families","volume":"31","author":"Wise","year":"1962","journal-title":"Q. J. Med."},{"key":"10.1016\/j.jns.2018.10.009_bb0205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(65)90086-0","article-title":"Angiokeratoma corporis diffusum universale (Fabry)","volume":"39","author":"Wallace","year":"1965","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2018.10.009_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/jhg.2010.18","article-title":"Cerebral hemorrhage in Fabry's disease","volume":"55","author":"Nakamura","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jns.2018.10.009_bb0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1526-4610.2006.00371.x","article-title":"\u201cBenign\u201d imaging abnormalities in children and adolescents with headache","volume":"46","author":"Schwedt","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.jns.2018.10.009_bb0220","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/head.12089","article-title":"Incidental white matter lesions in children presenting with headache","volume":"53","author":"Bayram","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.jns.2018.10.009_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2007.06.055","article-title":"Intracranial incidental findings on brain MR images in a pediatric neurology practice: a retrospective study","volume":"264","author":"Gupta","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.10.009_bb0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00247-013-2692-3","article-title":"Neuroimaging in childhood headache: a systematic review","volume":"43","author":"Alexiou","year":"2013","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.jns.2018.10.009_bb0235","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneur.61.9.1366","article-title":"Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis","volume":"61","author":"Swartz","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12883-015-0513-z","article-title":"Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia","volume":"15","author":"Fancellu","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2018.10.009_bb0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000369293","article-title":"Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease","volume":"38","author":"Fellgiebel","year":"2014","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0250","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000001333","article-title":"Thromboembolic events in Fabry disease and the impact of factor V Leiden","volume":"84","author":"Lenders","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.10.009_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: The European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2018.10.009_bb0260","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T04:30:05Z","timestamp":1541219405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18304192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":52,"alternative-id":["S0022510X18304192"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.009","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain MRI findings in children and adolescents with Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}